151 related articles for article (PubMed ID: 1969435)
1. The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit.
Barrett SP
J Hosp Infect; 1990 Feb; 15(2):137-42. PubMed ID: 1969435
[TBL] [Abstract][Full Text] [Related]
2. An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: value of topical mupirocin and of traditional methods of infection control.
Davies EA; Emmerson AM; Hogg GM; Patterson MF; Shields MD
J Hosp Infect; 1987 Sep; 10(2):120-8. PubMed ID: 2889764
[TBL] [Abstract][Full Text] [Related]
3. A major outbreak of methicillin resistant Staphylococcus aureus among patients and staff at Johannesburg Hospital during 1986-1987.
Park C; Pearce J
Nurs RSA; 1989; 4(6):37-9. PubMed ID: 2507921
[No Abstract] [Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital.
Duckworth GJ; Lothian JL; Williams JD
J Hosp Infect; 1988 Jan; 11(1):1-15. PubMed ID: 2895133
[TBL] [Abstract][Full Text] [Related]
5. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
6. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim HF; Vos MC
Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
[TBL] [Abstract][Full Text] [Related]
7. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.
Hill RL; Duckworth GJ; Casewell MW
J Antimicrob Chemother; 1988 Sep; 22(3):377-84. PubMed ID: 3141347
[TBL] [Abstract][Full Text] [Related]
8. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward.
Mayall B; Martin R; Keenan AM; Irving L; Leeson P; Lamb K
J Hosp Infect; 1996 Apr; 32(4):257-66. PubMed ID: 8744510
[TBL] [Abstract][Full Text] [Related]
9. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and control of the 'modern' methicillin-resistant Staphylococcus aureus.
Casewell MW
J Hosp Infect; 1986 Mar; 7 Suppl A():1-11. PubMed ID: 2871090
[No Abstract] [Full Text] [Related]
11. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N
J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473
[TBL] [Abstract][Full Text] [Related]
13. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
[TBL] [Abstract][Full Text] [Related]
14. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.
Dacre JE; Emmerson AM; Jenner EA
Lancet; 1983 Oct; 2(8357):1036. PubMed ID: 6138588
[No Abstract] [Full Text] [Related]
15. The carrier state: methicillin-resistant Staphylococcus aureus.
Casewell MW; Hill RL
J Antimicrob Chemother; 1986 Jul; 18 Suppl A():1-12. PubMed ID: 3091562
[No Abstract] [Full Text] [Related]
16. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients.
Ridenour G; Lampen R; Federspiel J; Kritchevsky S; Wong E; Climo M
Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1155-61. PubMed ID: 17828692
[TBL] [Abstract][Full Text] [Related]
17. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit.
Bartzokas CA; Paton JH; Gibson MF; Graham F; McLoughlin GA; Croton RS
N Engl J Med; 1984 Nov; 311(22):1422-5. PubMed ID: 6567778
[No Abstract] [Full Text] [Related]
18. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
20. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward.
Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S
J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
